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Abstract 
Background: The fabrication of silver nanoparticles (Ag-NPs) through green chemistry is an emerging area in the 
field of medical nanotechnology. Ag-NPs were fabricated by enzymatic reduction of AgNO3 using two lignin-degrad-
ing fungus Aspergillus flavus (AfAg-NPs) and Emericella nidulans (EnAg-NPs). The prepared Ag-NPs were characterized 
by different spectroscopic techniques. Antibacterial activity of prepared Ag-NPs was demonstrated against selected 
Gram negative (Escherichia coli and Pseudomonas aeruginosa) and Gram positive (Staphylococcus aureus) bacteria in 
the term of minimum bactericidal concentration (MBC) and susceptibility constant (Z). The synergistic antibacterial 
activity of Ag-NPs with four conventional antibiotics was also determined by the fractional inhibitory concentration 
index (FICI) using the checkerboard microdilution method. The antibiofilm potential of Ag-NPs was also tested.
Results: The plasmon surface resonance of biosynthesized Ag-NPs shows its characteristic peaks at UV and visible 
region (~450 and 280 nm). Fourier transform infrared spectrometer (FTIR) analysis confirms the nature of the capping 
agents as protein (enzyme) and indicates the role of protein (enzyme) in reduction of silver ions. The average parti-
cle size and charge of synthesized Ag-NPs was ~100 nm and ~−20 mV, respectively. X-ray diffraction (XRD) and TEM 
analysis confirmed the purity, shape, and size (quasi-spherical, hexagonal, and triangular) of Ag-NPs. Energy-dispersive 
X-ray spectroscopy (EDX) data validate the biological synthesis of Ag-NPs. Low MBC and high susceptibility constant 
indicate the high antimicrobial strength of biosynthesized Ag-NPs. The antibacterial analysis demonstrates the syner-
gistic antimicrobial activity of Ag-NPs with antibiotics. This study also shows that biosynthesized Ag-NPs have ability 
to inhibit the biofilm formation by 80–90 %.
Conclusion: The Aspergillus flavus and Emericella nidulans-mediated biosynthesized Ag-NPs have significant anti-
microbial activity and demonstrate synergistic effect in combination with antibiotics. It suggests that nanoparticles 
can be effectively used in combination with antibiotics to improve the efficacy of antibiotics against pathogenic 
microbes. The substantial antibiofilm efficiency of biosynthesized Ag-NPs would also be helpful against sensitive and 
multidrug-resistant strains.
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Background
Nanoparticles are currently an area of intense research 
due to a wide variety of potential applications in the bio-
medical, agricultural, optical, and electronic fields. Nano-
medicine has now become one of the leading research 
thrust areas which involves synthesizing safe, biocom-
patible, effective, cheap, and non-toxic drugs to combat 
diseases (Durán et  al. 2011; Keat et  al. 2015). From the 
ancient time, silver is used globally, as an antimicro-
bial agent and currently used in various areas like bio-
medical sciences, drug delivery, diagnostics, personal 
care products, cosmetics, and other fields viz. imaging, 
optics, sensing, painting, due to unearthing many of 
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its properties in the nanometer-sized form. In the area 
of nanomedicine, its popularity is due to its high anti-
microbial activity toward a broad range of pathogenic 
microbes and its relatively low toxicity toward humans 
(Sintubin et al. 2012; McShan et al. 2014; Khatami et al. 
2015). It has been well documented and experimentally 
proven that silver nanoparticle has the highest antimi-
crobial property among known synthesized metal nano-
particles, with high level of biocompatibility. It was also 
observed that the effectiveness of antimicrobial property 
of nanoparticles depends on its size and increases with a 
decrease in size (Pal et al. 2007; Chudasama et al. 2010; 
Nath and Banerjee 2013).
The formation of metal nanoparticle by different physi-
cal and chemical, conventional approaches, requires 
several highly toxic chemicals which results in toxic 
side effects (Nath and Banerjee 2013). Green chemistry 
mediated synthesis of nanoparticle is, however, one of 
the alternative routes that not only reduces or eliminates 
the use of hazardous, toxic, and expensive chemicals, 
but also confirms the safety and efficacy with respect to 
process and product. Green synthesis also provides the 
cost effective, non-toxic, large-scale, and high-output 
nanoparticle products (Keat et al. 2015; Roy et al. 2013). 
Green chemistry mediated formation of nanoparticle is a 
kind of “bottom up” approach, where the main reaction 
is reduction/oxidation. In biologically mediated nano-
particle synthesis, the microbial enzymes or plant phyto-
chemicals having reducing or antioxidant properties are 
usually responsible for the reduction of metal ions into 
their respective metal nanoparticles (Keat et  al. 2015; 
Nath and Banerjee 2013; Chaturvedi and Verma 2015). 
Biosynthesis of silver nanoparticles using bacteria, fungi, 
and plants is already well documented (Durán et al. 2011; 
Chaturvedi and Verma 2015; Ingle et  al. 2009; Thiruna-
voukkarasu et  al. 2013). In fungal community, various 
fungal strains have been well reported, as an efficient 
bio-factory for the synthesis of metal nanoparticles (Ingle 
et  al. 2009; Jaidev and Narasimha 2010; Saravanan and 
Nanda 2010).
Several reports have successfully demonstrated that 
Ag-NPs have antimicrobial activity against a broad range 
of gram-negative and gram-positive pathogenic bacteria 
including Escherichia coli, Pseudomonas aeruginosa, and 
Staphylococcus aureus (Keat et  al. 2015; Pal et  al. 2007; 
Ingle et  al. 2009; Jung et  al. 2008; Li et  al. 2011). The 
mechanism of the antimicrobial action of silver nano-
particle was proposed by different authors, in which the 
most common were the disruption in ATP production, 
error prone DNA replication, generation of reactive oxy-
gen species, failure of the proton motive force system, 
and direct damage to cell membranes (Marambio-Jones 
and Hoek 2010). Crystallographic surface structure and 
high surface-to-volume ratio amplify the contact area of 
metallic nanoparticles with a microorganism-influencing 
antibacterial activity of nanosized silver particle (Kora 
and Arunachalam 2011).
In the present study, Ag-NPs were biosynthesized 
extracellular using two fungi from Ascomycota member, 
Aspergillus flavus and Emericella nidulans. Biosynthe-
sized Ag-NPs were extensively characterized by differ-
ent spectrophotometric methods, and their synergistic 
antimicrobial activity with different classical antibiot-
ics was evaluated against three common opportunistic 
pathogenic bacteria by the checkerboard microdilution 
method. The antibiofilm potential of biosynthesized Ag-
NPs was also determined.
Methods
Reagents
All reagents were analytical grade and purchased from 
Merck Inc. (Mumbai, India). Antibiotics [Amikacin 
(AMI), Kanamycin (KAN), Oxytetracycline (OXY), 
Streptomycin (STR)] used in the experiments were pur-
chased from Sigma and Hi-Media (Mumbai, India). 
Ultrapure Milli-Q water (Elix, Merck Millipore, Mum-
bai, India) was used to prepare the antibiotic and Ag-NPs 
dilutions.
Source of microorganisms
Two fungal strains A. flavus (F10, NCBI accession no. 
KC911631.1) and E. nidulans (APF4, NCBI accession no. 
KC911632.1) reported for lignin degradation were used 
for the preparation of Ag-NPs. Three bacterial strains 
namely, E. coli (gram-negative rods, MTCC-739), P. aer-
uginosa (gram-negative cocci, MTCC-741), and S. aureus 
(gram-positive cocci, MTCC-96) were procured from the 
microbial-type culture collection (MTCC), IMTECH, 
Chandigarh, India and used in the investigation of anti-
microbial properties of Ag-NPs. All three bacterial cul-
tures were grown overnight on Luria–Bertani agar (LB) 
slants and maintained at 4 °C for further experiments.
Green synthesis of Ag‑NPs
Production of biomass
For the production of biomass, the fungus was grown 
aerobically in the liquid broth production medium. 
For A. flavus, Czapek Dox yeast broth (sucrose 30  g/L, 
yeast extract 5 g/L, MgSO4.7H2O 0.5 g/L, NaNO3 2 g/L, 
KCl 0.5  g/L, FeSO4.7H2O 0.001  g/L; pH-5.8) and for E. 
nidulans, Czapek Dox broth (sucrose 30  g/L, NaNO3 
2 g/L, K2HPO4 1 g/L, MgSO4.7H2O 0.5 g/L, KCl 0.5 g/L, 
FeSO4.7H2O 0.001  g/L; pH-5.8) were used, respectively. 
The culture flasks were incubated in static condition at 
37 and 27 °C, respectively. The fungal mat was separated 
from 5 days old production medium by filtration through 
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Whatman filter paper no. 4 and washed three times with 
sterile double-distilled water to remove the media com-
ponents from the biomass.
Synthesis of Ag‑NPs
Typically 10 g of biomass (wet weight) of both fungi was 
incubated in 100 mL sterilized Milli-Q water for 3 days 
at 27  °C in shaking condition on an orbital shaker at 
100  rpm. After the incubation, fungal suspension was 
separated by filtration through Whatman filter paper no. 
1 and the resulting filtrate was divided in two equal parts. 
In the first part of the filtrate, (50 mL) AgNO3 was added 
so that the final concentration of AgNO3 reached 1 mM, 
and the other half of filtrate (50  mL) devoid of AgNO3, 
served as a control. Both flasks were kept on orbital 
shaker at 27 °C in 100 rpm under dark conditions.
Characterization of Ag‑NPs
UV–visible spectrophotometry
The reduction of Ag+ ions and formation of Ag-NPs was 
monitored every 24 h by taking the UV-visible spectra of 
the reaction medium. After diluting an aliquot of 1  mL 
of the reaction medium with 2 mL Milli-Q water, spec-
tra was measured in the range of 250–700  nm using a 
UV-1800 spectrophotometer (Shimadzu, Japan).
Fourier transform infrared spectroscopy (FTIR)
FTIR measurements were performed to investigate the 
associated molecules with Ag-NPs. The Ag-NPs solu-
tion (100 mL) was centrifuged at 20,000 rpm for 10 min. 
The samples were dried and ground with potassium bro-
mide (KBr) pellets (1:100 w/w) and analyzed by Affinity-1 
model (Shimadzu, Japan) at a spectral range 4000–
400 cm−1 at a resolution of 4 cm−1. The FTIR analysis of 
cell-free extracts was also performed which serves as a 
reference.
Dynamic light scattering (DLS)
The particle size distribution and Zeta (ζ) potential meas-
urements of Ag-NPs were performed with a Zeta Sizer 
(Malvern Zeta Sizer Nano ZS90, UK) at room tempera-
ture. The sample preparation for zeta analysis involves 
the mixing of biosynthesized Ag-NPs in Millipore water 
in 1:10 (v/v) proportion, total volume of the sample was 
2 mL, taken in the clean zeta cell for the measurement of 
Zeta potential.
X‑ray diffraction (XRD)
XRD analysis was carried out using an X-ray powder dif-
fractometer (PANalytical 3  kW X’Pert Powder). The air 
dried nanoparticles were coated onto XRD grid and ana-
lyzed at a voltage of 40 kV and a current of 30 mA with 
Cu Kα monochromatic radiation (k  =  0.15406) (Fazay 
et al. 2011). The diffracted intensities were recorded from 
25 to 85 of 2θ angles with a step of 0.02° at room tem-
perature (27 °C).
Transmission electron microscopy (TEM)
TEM analysis was undertaken to know the size and shape 
of the Ag-NPs biosynthesized using fungus. After syn-
thesis of Ag-NPs, the sample was washed several times 
with sterilized Milli-Q water. TECNAI 20 G2 200  kV 
TEM (Fei, Electron Optics, Netherland) was employed to 
get the TAM images of Ag-NPs. A drop of the Ag-NPs 
solution was loaded on the carbon-coated copper grid 
and allowed to dry. A voltage of 200 kV and magnifica-
tion at 15,000× and 19,500× were used for observing the 
nanoparticles. The particle size of Ag-NPs was also deter-
mined through the image processing software ImageJ 
(Version 1.49, NIH, USA). The polydispersity of synthe-
sized Ag-NPs, based on TEM image data, was calculated 
according to Zhao et al. (2015).
Energy‑dispersive X‑ray spectroscopy (EDX)
EDX analysis was conducted using Phillips CM20-Ultra 
Twin microscope operating at 200 kV, to confirm the ele-
mental composition, associated with the Ag-NPs.
Analysis of antibacterial activity of biosynthesized Ag‑NPs
Determination of minimum bactericidal concentration (MBC) 
and susceptibility constant
The MBC of each Ag-NPs was determined by colony 
forming unit (CFU) assay as per following protocol. Test 
bacteria were grown in fresh LB medium at 37  °C in a 
gyratory shaker (Remi, India) at 135  rpm to obtain an 
optical density (OD) of 0.05 (correspond to ~108  cells/
mL) at 600 nm. In 10 mL of the above medium, different 
concentrations of Ag-NPs ranging from 1 to 64  µg/mL 
were added, and the culture tubes were allowed to incu-
bate at 37 °C in a gyratory shaker at 135 rpm for 18–20 h. 
Control cultures without nanoparticles were included in 
experiments, and the number of CFU (i.e., the number of 
bacteria present) recovered after the 18 h incubation was 
enumerated. From the above incubated cultures, a fixed 
amount of media was withdrawnserially diluted in saline 
(0.85  % NaCl, w/v). Properly diluted samples (100  µL) 
were spread on LB agar plates and incubated at 37 °C for 
18–24 h, until the colonies appeared and the numbers of 
CFU were counted manually. Final CFU was determined 
by multiplying the dilution factor with the viable num-
ber of colonies. The culture that showed the decrease of 
99.9 % in CFU after incubation was determined as MBC 
(Chatterjee et al. 2012).
Susceptibility constant of different bacteria against 
Ag-NPs was determined according to Chatterjee et  al. 
(Chatterjee et al. 2012). A higher Z value means a higher 
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sensitivity of bacteria toward the nanoparticles, and the 
nanoparticles have more effective antimicrobial activ-
ity. The susceptibility constant (Z) of a bacterial popu-
lation to an antimicrobial compound is calculated as 
Z = −In (N/N0)/C, where N0 and N are the numbers of 
living cells at 0 h and after 16–20 h incubation at the sub-
stance concentration C. Therefore, at MBC, Z = 3In10/
MBC = 6.908/MBC (Chatterjee et al. 2012).
Evaluation of synergistic effects between Ag‑NPs 
and antibiotics by broth microdilution checkerboard method
The degree of synergy between antibacterial drugs is 
often expressed in terms of the fractional inhibitory 
concentration (FIC). The FIC is the minimum inhibitory 
concentration (MIC) of the drug in combination divided 
by the MIC of drugs acting alone. Four antibiotics drugs, 
namely amikacin (AMI), kanamycin (KAN), oxytetra-
cycline (OXY), and streptomycin (STR) were used to 
examine their combined synergistic effects with pre-
pared Ag-NPs against the selected pathogenic bacterial 
species. Stock solutions of these agents were prepared 
in sterile Millipore water to a concentration from 1 to 
128  μg/mL and refrigerated at 2–4  °C. A checkerboard 
microdilution technique was used to examine the syn-
ergism between the antibiotics and Ag-NPs against test 
organisms.
For the determination of the factional inhibitory con-
centration (FIC), the microdilution “checkerboard” 
method was applied in microwell-containing plates. In 
this method, minimum inhibitory concentration (MIC) 
was determined, for both antibiotics and Ag-NPs alone 
and in their paired combinations (Isenberg 2007). For 
antibiotics and Ag-NPs, the test range was 0.5–128  μg/
mL. The sterility of prepared microwell plates was 
checked by incubation it in 37  °C for 24  h. Bacterial 
inoculum was prepared from an 18–24  h incubation of 
the test organism grown on Muller-Hinton broth (MHB). 
The organisms were harvested, and suspended in sterile 
MHB to produce a McFarland, 0.5 (turbidity equivalent 
to 108 colony forming units). The 0.5 McFarlands suspen-
sion was diluted in fresh MHB to achieve final CFU of 4 
× 106 to 5 × 106 from which 0.01 mL was inoculated into 
the microwells. The bacterial inoculated microtitre plates 
were incubated at 37 °C for 16–20 h.
The lowest concentration at which no visible growth 
occurred was recorded to be the MIC value of the indi-
vidual and combined test agents. FIC was calculated 
from the MIC of the test agent A and the MIC of the test 
agent A in combination with test agent B. Therefore, 
FIC of antibacterial A
= MIC of antibacterial A in combination/
MIC of antibacterial A alone
The FIC of antibacterial agent B was calculated in the 
same manner and the sum of the two FIC agents com-
bined to give the ΣFIC index. 
The calculated FIC index was used to detect the nature 
of interaction between the two test agents and the inter-
action either synergism or indifference or antagonism 
type. The values published by the American Society of 
Microbiology were used to decide the nature of the inter-
action FICI < 0.5 synergy, 0.5 ≤ FICI < 1 partial synergy, 
FICI = 1 additive, 2 ≤ FICI < 4 indifferent, and 4 < FICI 
antagonism (Botelho 2000).
Antibiofilm potential of Ag‑NPs
To determine the efficacy of Ag-NPs in biofilm for-
mation, 96-well microtiter plate method was applied 
(Kalishwaralal et  al. 2010). Individual wells of the sterile 
microtiter plate were filled with 180 μL of MH broth and 
inoculated with 10 μL of overnight grown culture. To the 
mixture, 10 μL of silver nanoparticles was added from the 
stock so that the final concentration of nanoparticle was 
achieved between 0.5 and 64 μg/mL. The microtiter plates 
were incubated for 24 h at 37  °C. After incubation, con-
tent of each well was gently removed and washed with 
0.2  mL of phosphate buffer saline (PBS, pH 7.2) three 
times, to remove free-floating ‘planktonic’ bacteria. Bio-
films formed by adherent ‘sessile’ organisms in plate wall 
were fixed with sodium acetate (2  %, w/v) and stained 
with crystal violet dye (0.1 %, w/v). Excess stain was rinsed 
off by thorough washing with sterilized Millipore water 
and plates were kept for drying. After drying, 200 μL of 
95 % (v/v) ethanol was added to the wells. The absorbance 
at 620 nm was measured on an ELISA reader (Multiskan® 
EX, Thermo Scientific, Finland), and values obtained were 
considered as an index of bacteria adhering to the surface 
of well wall for developing biofilms. The percentage of 
biofilm inhibition was calculated using the equation: 
Experiment was performed in triplicate, the data were 
then averaged, and the standard deviation was calculated. 
The fungal cell-free filtrate (10 μL), used for the Ag-NPs 
preparation, serves as a positive control.
Results and discussion
UV–visible spectroscopy
UV–visible spectroscopy is one of the simplest and most 
used technique for the preliminary characterization of silver 
FIC index = FIC of antibacterial A






OD620of cells treated with Ag−NPs
/OD620of non-treated control) × 100].
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nanoparticle. The optical signature of metal nanoparticles is 
given by the surface plasma resonance (SPR) and it is crucial 
to understand the number, position, and width of the SPRs 
as a function of the NP shape, size, and environment. SPR 
is affected by properties like surface charge distributions, 
dielectric medium, and surface-absorbed species, which are 
directly associated with nanoparticle size (Noguez 2007).
UV–visible spectra of fungal culture filtrate contain-
ing silver nanoparticles were obtained at regular time 
interval and presented in Figs.  1a, 2a. The extracellular 
synthesis of Ag-NPs was observed during incubation of 
culture filtrate of fungus and silver nitrate salts. A gradual 
change observed in coloration from light yellow to dark 
brown is an indication of the formation of Ag-NPs. From 
the spectral study, it was observed that E. nidulans syn-
thesized Ag-NPs (EnAg-NPs) show the surface plasmon 
resonance band maxima of silver nanoparticles centered 
at 450 nm, whereas A. flavus synthesized Ag-NPs (AfAg-
NPs) show the broad peak range from 420 to 450  nm. 
The intensity of peaks steadily increases with incuba-
tion time. Ag-NPs formed from both organism display 
a red shift in wavelengths from its characteristic reso-
nance peak for spherical silver nanoparticle at 420  nm. 
Noguez (Noguez 2007) explained that the small particle 
size metal nanoparticles (<40 nm) surface resonances do 
not change their characteristic position or frequency, but 
they become wider because of surface dispersion effects. 
However, with the increase in particles size and transfor-
mation in the nanoparticle morphology (i.e., spherical 
to the icosahedral/cuboctahedron/truncated cube), the 
optical absorption spectra of metal nanoparticles, domi-
nated by surface plasmon resonances (SPR), shift toward 
longer wavelengths and also make the peaks broader. A 
broadening in the absorption peak of AfAg-NPs can be 
also explained by Mie’s theory. Mie’s theory explains that 
the number of SRP bands of the nanoparticle is depend-
ent on its shape. Spherical nanoparticle produces single 
SRP band while the anisotropic particle produces more 
SRP bands in optical absorption spectra (Pal et al. 2007). 
A small shoulder also appears in the absorption spectrum 
of EnAg-NPs at ∼360 nm, which may be due to smaller 
colloids, absorbing at shorter wavelengths.
Fig. 1 Characterization of E. nidulans synthesized silver nanoparticles a UV–visible spectra, b FTIR spectrum, c histogram of particle size distribution, 
d zeta potential
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Both EnAg-NPs and AfAg-NPs spectra produce an 
absorption peak in UV region at 280 nm. This peak may 
be due to the electronic extinction of aromatic amino acid 
(tryptophan and tyrosine) in protein residue (Vignesh-
waran et  al. 2007; Fayaz et  al. 2010). This observation 
suggests the involvement of extracellular proteins of fun-
gus in the formation and stability of the nanoparticles.
FTIR analysis
The FTIR analysis was performed to identify the func-
tional group of the attached capping biomolecule, 
responsible for the reduction, synthesis, or stabilization 
of the nanoparticles. The FTIR spectra (Figs.  1b, 2b) of 
both Ag-NPs display bands at 1388 and 1385 cm−1 which 
is assigned for functional group of residual NO3− (Ramas-
wamy et al. 2012). EnAg-NPs display bands at 2914 and 
1534  cm−1 which were assigned to the main and the 
corresponding stretching vibration of –N–H in second-
ary amine (amide II) while 1647  cm−1 was assigned for 
–C=O stretch vibration in primary amine (amide I). Band 
observed at 1510 and 1030  cm−1 can be allotted to the 
amide II functional group and C–N stretching vibration 
of aliphatic amine, respectively. FTIR spectrum of AfAg-
NP displays bands corresponding to stretching vibra-
tion of –N–H in secondary amine (amide II) at 2913 and 
1556  cm−1, whereas band at 1621  cm−1 correspond to 
–C=O of the primary amine (amide I). Band at 1273 cm−1 
is corresponding to strong stretching vibrations of C–N 
aromatic and aliphatic amines. All the above peaks pre-
sent in Ag-NPs IR spectrum, are also present in the IR 
spectrum of the cell-free filtrate of both fungi (Figs. 1b, 
2b). The absorbance of all corresponding peaks was high 
in cell-free filtrate as compared to the Ag-NPs. The pres-
ence of all above signature peaks of amino acids in the 
IR spectrum, confirms the presence of proteins/enzymes 
in the cell-free filtrate as well as in both Ag-NPs (Fazay 
et al. 2011; Jain et al. 2011). Peak at 1027 cm−1, suggested 
the involvement of phosphate bonds in the reduction 
of silver ion (Durán et  al. 2011). Ingle et  al. (2009) and 
Ramaswamy et al. (2012) also reported that the biologi-
cal synthesis of Ag-NPs is mediated through the proteins 
(enzymes) like NADH-dependent nitrate reductase of 
source microorganism. In protein, carbonyl group, amine 
groups, cysteine residues, and peptides have stronger 
Fig. 2 Characterization of A. flavus synthesized silver nanoparticles a UV–visible spectra, b FTIR spectrum, c histogram of particle size distribution, d 
zeta potential
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ability to bind and stabilize silver ions through the elec-
trostatic attraction (Durán et al. 2011; Jain et al. 2011).
Particle size distribution and zeta potential
The particle size and the zeta potential of the prepared 
nanoparticle are the main factors that interfere with the 
biological activities and its reaction with other active 
charge surface. The antimicrobial mechanism of nano-
particles varies, depending on their variation in particle 
size and zeta potential (Bihari et al. 2008).
From Figs. 1c, 2c it is evident that the Ag-NPs formed 
by fungus have a wide range of size. The EnAg-NP dis-
plays a range from 36 to 531 nm while AfAg-NPs were in 
the range of 37–340 nm. The z-average values for EnAg-
NPs and AfAg-NPs were 98.92 and 103.96, respectively, 
whereas the polydispersity index (PDI) was low i.e., 
0.272 and 0.224, respectively. The surface zeta poten-
tial values of Ag-NPs (Figs. 1d, 2d) were measured to be 
slightly negative and were −20.4 mV for EnAg-NPs and 
−19.9 mV for AfAg-NPs. The negative charge of Ag-NPs 
prevents them from aggregation and increases their sta-
bility, as well as help enhance their antimicrobial prop-
erty. The possible cause of the negative surface charges 
on synthesized Ag-NPs is the absorption of free nitrate 
ions present during the reduction of AgNO3 (Kim et al. 
2007).
X‑ray diffraction analysis
The XRD patterns of the prepared Ag-NPs from E. nidu-
lans and A. flavus are shown in Figs. 3a, 4a. The Fig. 3a, 
shows diffraction peaks for EnAg-NPs, (2θ) at 38.2°, 
44.4°, 64.6°, 77.5°, and 81.7°, which can be indexed to the 
(111), (200), (220), (311), and (222) planes of the face-
centered cubic (fcc) silver (Joint Committee on Powder 
Diffraction Standards file no. 04-0783). It confirmed sil-
ver as the main component of the nanoparticle. The pre-
dominant orientation was the (111) plane because the 
most intense peak appeared at 38.2°. The diffractogram 
did not suggest the presence of possible impurities such 
as AgNO3 or Ag2O (Fazay et al. 2011), whereas AfAg-NP 
diffractogram (Fig.  4a) shows the diffractions at 38.3°, 
44.4°, 64.6°, 77.47°, and 81.6° that can be indexed to the 
(111), (200), (220), (311), and (222) planes of the fcc. In 
the AfAg-NPs diffractogram, some other peaks at 28°, 
32.3°, 46.3°, 54°, and 57.8° were also produced. The for-
mation of these peaks in XRD diffractogram might be 
due to the presence of associated contaminations with 
biosynthesized Ag-NPs. Yoon et al. (2007) also found the 
peaks at 28° and 32.3° in XRD diffractogram of fungus-
mediated Ag-NPs and suggested that the origin of these 
peaks might be due to the interaction of silver with the 
fungal cell wall.
EDX
The elemental analysis of the Ag-NPs was performed 
using the EDX. The EDX spectrum of the biosynthe-
sized Ag-NPs is shown in Figs. 3b, 4b, which reveals the 
existence of various elements. In both EDX spectra of 
Ag-NPs, peaks around 3  keV correspond to the binding 
energies of AgL (Jain et  al. 2011), while the peaks of Nk, 
Ck, Ok, and Kk were situated near the 0.5 keV. In spectra, 
the weight  % of Ag was 34.01 and 41.42, for EnAg-NPs 
and AfAg-NPs, respectively. Also, a peak near 1.1  keV 
corresponding to Nak and Mgk, was observed. Beside Ag, 
there are other elemental peaks bands for S, Mg, N, C, O, 
and P that also appeared throughout the scanning range 
(0–4 keV) of the spectrum suggesting that the biological 
origin molecule i.e., enzymes or proteins were attached 
with the biosynthesized Ag-NPs, further the presence of 
protein or enzyme like molecule was also confirmed by 
the UV–visible and FTIR spectroscopy (Durán et al. 2011; 
Jain et al. 2011; Li et al. 2012). From the EDX results it was 
also proposed that the synthesized Ag-NPs might be sta-
bilized through these proteins or enzyme. Li et al. (2012) 
also studied the Ag-NPs preparation through A. terreus 
supernatant and confirmed that the NADP-dependent 
reductase was involved in the formation of Ag-NPs. The 
overall results indicate that the synthesized Ag-NPs were 
formed by the enzymatic reduction.
Transmission electron microscopic analysis
Morphology of the synthesized Ag-NPs was character-
ized by TEM study. Figures 3c, 4c show the TEM image 
for E. nidulans and A. flavus, respectively, captured from 
the nanoparticle-coated carbon grid. The EnAg-NPs dis-
play a high uniformity in comparison to AfAg-NPs. As 
evident in Fig. 3c morphology of EnAg-NPs were mono 
dispersive and mostly having hexagonally shaped nano-
particle, while A. flavus (Fig.  4c) formed mostly quasi-
spherical Ag-NPs, few were triangular and hexagonal in 
shape. The particle size of both Ag-NPs ranges from 30 
to 150 nm as deduced by TEM micrograph. The particle 
size histogram (EnAg-NPs and AfAg-NPs) based on the 
TEM image (Figs. 3d, 4d) shows that the most of Ag-NPs 
come under the ranges of 10–450  nm, and in both fre-
quency distribution histogram of Ag-NPs the major por-
tion of particles (80–90 %) fall in the range of 5–100 nm. 
Based on the TEM image analysis by ImageJ software, it 
was determined that EnAg-NPs and AfAg-NPs possess 
an average particle size of 66.68 and 81.11  nm, respec-
tively. These results are in agreement with the values 
obtained by DLS measurements. The polydispersity 
indices of EnAg-NPs and AfAg-NPs are 48.83 and 18.68, 
respectively, as determined by the ImageJ software Ag-
NPs size calculation.
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It was seen that through the enzymatic synthesis 
process, the formation of quasi-spherical NPs was 
most common, but the morphology of NP depends 
on the metal ion solution, concentration of biomole-
cule produced by the microbes, incubation time, and 
incubation condition (Quester et  al. 2013). Several 
other members from same fungal family were also 
reported for the Ag-NPs formation viz. A. fumigatus 
[mostly spherical some triangular, 5–25  nm; (Bhainsa 
and D’Souza 2006)], A. flavus [spherical; 17 nm, (Jain 
et  al. 2011)], A. clavitus [550–650  nm; (Saravanan 
and Nanda 2010)], A. terreus [spherical, 1–20 nm; (Li 
et al. 2012)] A. niger [spherical, 3–30 nm; (Jaidev and 
Narasimha 2010)], A. temerii [spherical, 25–50  nm; 
(Ramaswamy et  al. 2012)]. The literature thus sug-
gests that most of the fungi of this family synthesize 
spherical-shaped Ag-NPs till date, and to the best of 
our knowledge, this is the first report in contrast to the 
extracellular synthesis of Ag-NPs by E. nidulans and as 
well as the hexagonal- and triangular-shaped Ag-NPs 
formed by both of this fungus.
MBC and Susceptibility constant
To investigate the antibacterial potential (MBC) of the 
silver nanoparticle against E. coli, S. aureus, and P. aer-
uginosa, a broth dilution method and the conventional 
plate count technique (CFU counting) were carried out 
in LB medium. All test bacterial strains (approximately 
108  cells/mL) were grown overnight in the presence of 
different concentrations of Ag-NPs (1–64 µg/mL). After 
18–24 h incubation, the viability of the bacterial cells was 
determined by CFU counting. The MBC values of both 
Ag-NPs are presented in Table  1. The results show that 
the efficacy of AfAg-NPs was higher than EnAg-NPs, 
against E. coli with lower MBC. In case of P. aeruginosa, 
AfAg-NPs was found more potently bactericidal than 
EnAg-NPs, while against S. aureus, EnAg-NPs was more 
effectively bactericidal than AfAg-NPs.
Pelletier et  al. (2010) suggested that the reactiv-
ity of nanoparticle against microbes is highly depend-
ent on the morphology as well as surface-to-mass ratio. 
Smaller, uneven, and irregular-shaped particle has dif-
ferent binding characteristic with the microbial surface, 
Fig. 3 Characterization of E. nidulans synthesized silver nanoparticles a XRD diffractogram , b EDX spectrum, c TEM image, and d Particle size distri-
bution histogram (based on TEM image)
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due to itsbiological and chemical reactive edges and 
corners. The Ag-NPs prepared from both fungi have a 
wide range of particle size distribution. Results show an 
effective bactericidal activity against test organisms. Pal 
et al. (2007) explained the shape-dependent antimicrobial 
activity of nanoparticles in the term of active facets. They 
found that the high atom density facets, such as {111} 
facets have high antimicrobial activity. The result in the 
present study is in strong agreement with the XRD result 
of nanoparticle. Both nanoparticles show a prominent 
peak of {111} facets. The XRD pattern correlated with 
TEM analysis that there are lots of differently shaped viz. 
hexagonal-, triangular-, and quasi-spherical-shaped nan-
oparticles present in the sample, and contain high {111} 
facets, which increase their antibacterial activity.
Along with the MBC, the susceptibility constant (Z) 
is also an important factor in the antimicrobial study of 
silver nanoparticles, which is a quantitative parameter 
for antimicrobial power toward specific bacteria (Yoon 
et al. 2007). In the present study, the Z values of E. coli, 
P. aeruginosa, and S. aureus of EnAg-NPs are 0.216, 
0.216, and 0.288  mL/μg, respectively, while in the case 
of AfAg-NPs, it is 0.288, 0.216, and 0.288 mL/μg. These 
results depict that S. aureus is most sensitive, whereas 
P. aeruginosa was most resistant toward both Ag-NPs. 
While E. coli was more sensitive toward AfAg-NPs than 
EnAg-NPs. The difference in the activity of Ag-NPs 
was possibly due to the difference in the membrane 
structure of Gram-negative and Gram-positive bacte-
ria. Physical interaction of Ag-NPs with the bacterial 
Fig. 4 Characterization of A. flavus synthesized silver nanoparticles a XRD diffractrogram, b EDX spectrum, c TEM image, and d particle size distribu-
tion histogram (based on TEM image)
Table 1 Minimum bactericidal concentration (MBC; in  µg/
mL) of the both Ag-NPs
Test organism Ag‑NPs synthesized by
E. nidulans A. flavus
S. aureus 24 > MBC > 16 MBC ≤ 24
E. coli 32 > MBC > 24 24 > MBC > 16
P. aeruginosa 64 > MBC > 32 32 > MBC > 24
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cell may lead to increased membrane permeability and 
cause physical damage, which ultimately leads to cell 
death.
Synergistic effect of Ag‑NPs with different antibiotics
The synergistic effects of Ag-NPs were also investigated 
with four conventional antibiotics against pathogenic 
bacteria using checkerboard microdilution method 
and the effects were evaluated by determination of the 
FICI. The results of the synergistic effect in the form of 
ƩFIC range and mean FIC are presented in Tables  2, 3, 
respectively. All of the combinations demonstrated syn-
ergistic and partial synergistic effect against the tested 
bacteria. An enhanced antibacterial synergistic activ-
ity of EnAg-NPs and three antibiotics (KAN, OXY, and 
STR) was found against S. aureus, whereas AfAg-NPs 
with all antibiotics show partial synergism. The AfAg-
NPs display more antibacterial activity than EnAg-NPs 
against S. aureus. In the case of E. coli, both Ag-NPs show 
synergistic activity with AMI and STR, while other two 
display partial synergism. A partial synergistic interac-
tion of AfAg-NPs was observed with all four antibiotics 
against P. aeruginosa, whereas EnAg-NPs produce par-
tial synergistic with AMI and STR. The other combina-
tional activities (EnAg-NPs with KAN and OXY) were 
found as antagonistic activity against P. aeruginosa. These 
synergistic activities of Ag-NPs in the presence of con-
ventional antibiotics suggest that it might be possible to 
reduce the viability of bacterial strains at lower antibiotic 
concentrations.
Our results concur the report by Hwang et  al. (2012) 
study, in which they also found the synergistic effect of 
Ag-NPs with AMI against E. coli. They also found the 
synergistic effect of Ag-NPs and KAN against all three 
test organisms. They proposed such results might be due 
to the differences in size of prepared Ag-NPs. Fayaz et al. 
(2010) also studied the combined antimicrobial effect of 
antibiotics and Ag-NPs and suggested that the increase in 
synergistic effect may be caused by the bonding reaction 
between antibiotic and Ag-NPs. Birla et  al. (2009) also 
observed the enhanced synergistic antimicrobial effect of 
antibiotics like vancomycin, gentamycin, streptomycin, 
ampicillin, and kanamycin when applied in combination 
with Ag-NPs against P. aeruginosa, S. aureus, and E. coli. 
In literature, it is proposed that the antimicrobial action 
of Ag-NPs occurs through the alteration of cell membrane 
permeability, morphology, separation of the cytoplasmic 
membrane from the cell wall, plasmolysis, breakdown of 
DNA, and inhibition of respiratory activity (Jung et  al. 
2008; Li et  al. 2011; Fayaz et  al. 2010; Birla et  al. 2009). 
From the results of present study, it is proposed that the 
Ag-NPs might be disrupting the bacterial cell wall struc-
ture and surface charge balance, which eventually change 
the permeability of bacterial cell wall due to which antibi-
otics have better opportunity to approach the individual 
bacterial cell associated with biofilm.
Antibiofilm potential of Ag‑NPs
According to the report of the National Institutes of 
Health and Center of Disease control, about ~65–80  % 
Table 2 The ΣFIC index range of Ag-NPs with four antibiotics against three test bacterial strains
ND not detected
S. aureus E. coli P. aeruginosa
E. nidulans A. flavus E. nidulans A. flavus E. nidulans A. flavus
AMI 0.188–1.5 0.5–0.625 0.094–0.75 0.078–0.625 0.312–1.5 0.31–1.25
KAN 0.14–1.125 0.094–0.375 0.078–2.5 0.14–1.25 ND 0.515–1.031
OXY 0.133–1.063 0.07–0.281 0.078–2.5 0.14–1.25 ND 0.265–1.063
STR 0.156–1.25 0.07–0.281 0.069–0.565 0.07–0.565 0.07–1.125 0.31–1.25
Table 3 The ΣFIC index mean of Ag-NPs with four antibiotics against three test bacterial strains
PS partial synergistic, S synergistic, A antagonism, ND not detected
S. aureus E. coli P. aeruginosa
E. nidulans A. flavus E. nidulans A. flavus E. nidulans A. flavus
AMI 0.713PS 0.563PS 0.351S 0.051S 0.887PS 0.859PS
KAN 0.726PS 0.258S 0.716PS 0.523PS NDA 0.945PS
OXY 0.55PS 0.231S 0.963PS 0.712PS NDA 0.841PS
STR 0.509PS 0.129S 0.364S 0.332S 0.679PS 0.687PS
Page 11 of 13Barapatre et al. Bioresour. Bioprocess.  (2016) 3:8 
infections occurred by biofilm formation microbes, amid 
which the Gram-negative bacterium P. aeruginosa, E. coli, 
and the Gram-positive staphylococci, S. aureus are the 
most common ones (Joo and Otto 2012). Ag-NPs have an 
exclusive ability to disrupt biofilm of several pathogenic 
bacteria. Biosynthesized Ag-NPs were tested for biofilm 
inhibition potential against E. coli, P. aeruginosa, and S. 
aureus, having known of their ability to form biofilm. Test 
organisms were grown in microtiter plate wells with and 
without Ag-NPs to form biofilm for 24 h. The treatment 
of cell-free filtrate (positive control) did not show any 
significant decrease in the biofilm formation. The fungal 
cell-free filtrate showed 4–6 % antibiofilm activity in the 
absence of Ag-NPs, while treatment with concentration 
of 0.5–64 µg/mL of both Ag-NPs resulted in a significant 
decrease of 74–84 % (Figs. 5, 6) in the biofilm formation. 
In the both cases, the amount of biofilm formation was 
sharply decreased by increase in Ag-NPs concentration. 
The AfAg-NPs (at 2  μg/mL) reduce the biofilm forma-
tion up to 70 % in both gram-negative bacteria, whereas 
with gram-positive bacteria, it produces 30 % reduction. 
While in case of EnAg-NPs, the ≥50 % inhibition in bio-
film formation was seen at 4 μg/mL for S. aureus and P. 
aeruginosa, and 8 μg/mL for E. coli. The IC50 values for 
AfAg-NPs were 9.9, 1.817, and 3.207  µg/mL against S. 
aureus, P. aeruginosa, and E. coli, respectively, whereas 
in case of EnAg-NPs these are 18.06, 4.165, and 10.08 µg/
mL, respectively. From the above data, it was seen that 
the AfAg-NPs were better antibiofilm agents against the 
gram-negative bacteria than the EnAg-NPs. This differ-
ence in the inhibitory activity of both Ag-NPs can also 
be explained by several factors, including efficacy in anti-
microbial activity, physical properties like size of nano-
particles, which affect the limited penetration and other 
chemical properties like affinity between the materi-
als and the biofilms (Park et al. 2013). Park et al. (2013) 
also proposed that the biosorption might be responsible 
for the biofilm inactivation in P. aeruginosa, and Ag-
NPs inactivated P. aeruginosa biofilm cells in a biosorp-
tion-dependent manner. Kalishwaralal et  al. (2010) also 
demonstrated that nanoparticles inhibited P. aeruginosa 
growth by ceasing the exopolysaccharide synthesis, con-
sequently inhibiting biofilm formation. They found that 
50 nM of Ag-NPs significantly arrested biofilm formation 
without affecting viability, whereas 100 nM inhibited the 
growth of the P. aeruginosa itself and led to 95 % reduc-
tion in biofilm. Goswami et  al. (2015) also studied the 
Ag-NPs mediated biofilm eradication, and found inhibi-
tion of 89 % for S. aureus and 75 % for E. coli at 15 mg/
mL. The data in the present study validate that Ag-NPs 
can effectively and rapidly detach biofilm, produced by E. 
coli, P. aeruginosa, and S. aureus at clinically achievable 
concentrations of silver nanoparticles. This implies, the 
application of these Ag-NPs as biofilm-disrupting agents.
Fig. 5 Determination of  % antibiofilm inhibition of E. nidulans synthesized silver nanoparticles (EnAg-NPs) on E. coli, P. aeruginosa, and S. aureus by 
microtiter plate method
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Conclusions
In the present study, the biosynthesis method used for syn-
thesizing Ag-NPs has a distinct advantage over chemical 
synthetic techniques such as a high efficiency, biocompat-
ibility, ecofriendly, and low toxicity to the environment. In 
this work, a new fungal source (E. nidulans) is reported as 
a potential source of Ag-NPs synthesis. As per the avail-
able knowledge, we are the first to report the formation 
of hexagonal-shaped Ag-NPs by the fungus as confirmed 
by TEM analysis. UV–visible absorbance spectral analysis 
confirmed the surface plasmon resonance of biosynthe-
sized Ag-NPs. XRD, FTIR, and EDX provided additional 
strong evidence of biological synthesis of Ag-NPs and the 
crystallinity of the synthesized Ag-NPs. Furthermore, the 
biosynthesized Ag-NPs displayed a pronounced antimi-
crobial and antibiofilm potential against different clini-
cally important pathogenic microorganisms. Since high 
CFU is applied in this study, it appears that these particles 
could have an excellent bactericidal effect and are effec-
tive in reducing bacterial growth for practical applica-
tions and the formulation of various biocidal materials. 
The synergistic action of antimicrobial agents can reduce 
the need for high dosages and minimize side effects. This 
study demonstrates the synergistic effect of antibiotics and 
nanoparticles in improving their bactericidal property; it 
was suggested that nanoparticles can be effectively used in 
combination with antibiotics in order to improve their effi-
cacy against various pathogenic microbes.
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